• Corpus ID: 16865412

GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report.

@article{Shulman2002GABAAbenzodiazepinechlorideRT,
  title={GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report.},
  author={Abraham Shulman and Arnold M. Strashun and Barbara A Goldstein},
  journal={The international tinnitus journal},
  year={2002},
  volume={8 1},
  pages={
          30-6
        }
}
Our goal was to attempt to establish neuropharmacological tinnitus control (i.e., relief) with medication directed to restoration of a deficiency in the gamma-aminobutyric acid-benzodiazepine-chloride receptor in tinnitus patients with a diagnosis of a predominantly central type tinnitus. [] Key Method Thirty tinnitus patients completed a medical audiological tinnitus patient protocol and brain magnetic resonance imaging and single-photon emission computed tomography of brain.

Figures and Tables from this paper

Gabapentin and tinnitus relief.

  • A. Shulman
  • Medicine
    The international tinnitus journal
  • 2008
GP, a drug designed originally as a supplement for seizure control, was considered for those SIT patients in whom objective evidence of abnormal electrical and metabolic brain activity was identified.

Gabapentin effectiveness on the sensation of subjective idiopathic tinnitus: a pilot study

There was not a significant subjective improvement in tinnitus annoyance for the patients (37%) versus controls (42%) and comparison between the results before and after intervention for patients and controls showed no significant differences (P > 0.05).

Short-Term Effect of Gabapentin on Subjective Tinnitus in Acoustic Trauma Patients

This double-blind, randomized clinical trial concludes that gabapentin 300 mg bid for 6 weeks is an effective treatment for acoustic tinnitus and the placebo effect in relievingTinnitus is remarkable.

Principles of tinnitology: tinnitus diagnosis and treatment a tinnitus-targeted therapy.

The ongoing clinical application of a rationale based on principles of diagnosis and treatment for SIT, which has evolved from the TTT clinical experience in SIT patients, continues to result in long-term tinnitus relief.

Analysis of Gabapentin’s Efficacy in Tinnitus Treatment: A Systematic Review

There is insufficient evidence to recommend the use of gabapentin for patients with tinnitus, according to the critical evaluation checklist for randomized controlled trials.

Administration of the Combination Clonazepam-Deanxit as Treatment for Tinnitus

  • O. MeeusD. De RidderP. H. Van de Heyning
  • Medicine
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • 2011
This article provides valuable data demonstrating a placebo-controlled tinnitus reduction after clonazepam and Deanxit intake, respecting a double-blind placebo- controlled approach for Deanxit in a crossover setup.

Pharmacotherapy for severe, disabling, subjective, idiopathic tinnitus: 2005-2006.

A tinnitus-targeted therapy (TTT), a combined treatment of medication and instrumentation focusing on pharmacotherapy that contributes to the development of a new discipline, tinnitology, an integrated multidiscipline of basic science, neuroscience, and clinical medicine attempting to understand an aberrant auditory phenomenon, unrelated to an external source of sound, and how it becomes transformed into one of affect.

Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin.

Addition of GABAergic to benzodiazepine drugs does not modify the treatment results in SDT of a predominantly cochlear origin, and statistically significant improvement is found in comparing groups 2 and 3 with group 1 but found no significant difference when groups2 and 3 were compared.

Treatment Response of Modified Tinnitus Retraining Therapy with Medical Therapy in the Patients with Tinnitus

Modified TRT, in addition to medical therapy, should be considered to increase the therapeutic response in patients with sensorineural tinnitus.
...

References

SHOWING 1-10 OF 27 REFERENCES

Benzodiazepine receptor deficiency and tinnitus.

Preliminary results of diminished benzodiazepine-binding sites in the medial temporal cortex of all patients with severe tinnitus are revealed, a finding that is consistent with the hypothesis implicating GABAergic mechanisms in the pathophysiology of the disorder.

Neuroprotective Drug Therapy: A Medical and Pharmacological Treatment for Tinnitus Control.

  • Shulman
  • Medicine
    The international tinnitus journal
  • 1997
The goal of this article is to introduce to the neurootologist or otologist and other professionals attempting tinnitus control neuroprotective drug therapies that are being applied to such central nervous system pathological processes as ischemia, trauma, hemorrhage, and neurodegeneration.

Tinnitology, Tinnitogenesis, Nuclear Medicine, and Tinnitus Patients.

  • Shulman
  • Medicine
    The international tinnitus journal
  • 1998
To patients with subjective idiopathic tinnitus, nuclear medicine techniques of positron emission tomography and single-photon emission computed tomography provide correlation of structure and function, which improves the accuracy of theTinnitus diagnosis.

A Final Common Pathway for Tinnitus - The Medial Temporal Lobe System.

  • Shulman
  • Biology, Medicine
    The international tinnitus journal
  • 1995
The overall hypothesis of a final common pathway for tinnitus; the role of the MTLS; and clinical support for this hypothesis is presented.

SPECT Imaging of Brain and Tinnitus-Neurotologic/Neurologic Implications.

SPECT results of brain demonstrate for the first time the in vivo significance of the organicity of brain for a central type of tinnitus.

The medical audiological evaluation of tinnitus patients.

  • J. Seabra
  • Medicine
    The international tinnitus journal
  • 1999
We outline our routine approach to tinnitus patients, highlighting the different aspects of our examination: the clinical history, objective ear, nose, and throat and general examination, and

Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues

The γ2+/– mice represent a model of anxiety characterized by harm avoidance behavior and an explicit memory bias for threat cues, resulting in heightened sensitivity to negative associations.

Generating diversity at GAB Aergic synapses